ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 693543 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 693543; 2) Community: the network communities that were significantly associated with the response to NSC 693543; 3) Molecule: the relationships between components within communities and NSC 693543; 4) MDR: the compounds that were significantly associated with the NSC 693543.

NSC Compound Enrichment Correlation
NSC 728091 6-[(3-Hydroxy)-1-propyl]-5,6-dihydro-2,3-dimethoxy-8,9-methy lenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline 0.0178844438004195 0.19174077
NSC 735037 Camptothecin Derivative 0.0178844438004195 0.33508531
NSC 740520 6-(3-Bromopropyl)-9-fluoro-5,6-dihydro-2,3-dimethoxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline 0.0178844438004195 0.25692
NSC 740524 6-(3-Azidopropyl)-9-fluoro-5,6-dihydro-2,3-dimethoxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline 0.0178844438004195 0.20425953
NSC 750227 Null 0.0178844438004195 0.22155679
NSC 697192 Decanediamide, N,N'-bis[2-(2-hydroxy-1-naphthalenyl)- 5-(3,4-dihydroxyphenyl)methylene]-4-oxo- 3-thiazolidinyl]- 0.0179905510964914 0.077741088
NSC 699702 Null 0.0179905510964914 0.25245315
NSC 709237 Camptothecin Derivative 0.0179905510964914 0.29848126
NSC 713019 Null 0.0179905510964914 0.34583613
NSC 723531 Resveratrol-3,5-diacetate 0.0179905510964914 0.10267043
Total:62  Current:25    [First] [Prev] [Next] [Last]